Neutralization serotypes of human immunodeficiency virus type 1 field isolates are not predicted by genetic subtype

被引:114
|
作者
Weber, J
Fenyo, EM
Beddows, S
Kaleebu, P
Bjorndal, A
Osmanov, S
Heyward, W
Esparza, J
GalvaoCastro, B
vandePerre, P
Karita, E
Wasi, C
Sempala, S
Tugume, B
Biryahwaho, B
RubsamenWaigmann, H
vonBriesen, H
Esser, R
Grez, M
Holmes, H
Newberry, A
Ranjbar, S
Tomlinson, P
Bradac, J
McCutchan, F
Louwagie, J
Hegerich, P
LopezGalindez, C
Olivares, I
Dopazo, J
Mullins, JI
Delwart, EL
Bachmann, HM
Goudsmit, J
deWolf, F
Hahn, BH
Gao, F
Yue, L
Saragosti, S
Schochetman, G
Kalish, M
Luo, CC
George, R
Pau, CP
CheingsongPopov, R
Nara, P
Albert, J
Myers, G
Korber, B
机构
[1] KAROLINSKA INST,MICROBIOL & TUMOUR BIOL CTR,S-10401 STOCKHOLM,SWEDEN
[2] WHO,GLOBAL PROGRAMME AIDS,CH-1211 GENEVA,SWITZERLAND
[3] OSWALDO CRUZ FDN,SALVADOR,BA,BRAZIL
[4] NATL HIV AIDS REFERENCE LAB,KIGALI,RWANDA
[5] MAHIDOL UNIV,DEPT MICROBIOL,BANGKOK 10700,THAILAND
[6] UGANDA VIRUS RES INST,ENTEBBE,UGANDA
[7] GEORG SPEYER HAUS CHEMOTHERAPEUT FORSCHUNGSINST,FRANKFURT,GERMANY
[8] NATL INST BIOL STAND & CONTROLS,LONDON NW3 6RB,ENGLAND
[9] NIAID,DIV AIDS,BETHESDA,MD 20892
[10] WALTER REED ARMY INST RES,HENRY M JACKSON FDN LAB,ROCKVILLE,MD
[11] INST SALUD CARLOS III,CTR NACL BIOL CELULAR & RETROVIRUS,MADRID,SPAIN
[12] STANFORD UNIV,SCH MED,DEPT MICROBIOL & IMMUNOL,STANFORD,CA 94305
[13] UNIV AMSTERDAM,ACAD MED CTR,HUMAN RETROVIRUS LAB,NL-1105 AZ AMSTERDAM,NETHERLANDS
[14] UNIV ALABAMA,DEPT MED,BIRMINGHAM,AL 35294
[15] INST COCHIN,PARIS,FRANCE
[16] CTR DIS CONTROL & PREVENT,ATLANTA,GA 30333
[17] ST MARYS HOSP,SCH MED,LONDON,ENGLAND
[18] NCI,VIRUS BIOL UNIT,FREDERICK,MD 21701
[19] SWEDISH INST INFECT DIS CONTROL,STOCKHOLM,SWEDEN
[20] LOS ALAMOS NATL LAB,LOS ALAMOS,NM 87545
关键词
D O I
10.1128/JVI.70.11.7827-7832.1996
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human immunodeficiency virus type 1 (HIV-1) primary isolates from four geographical locations in Thailand, Brazil, Rwanda, and Uganda, representing genetic subtypes A, B, C, D, and E, were examined for autologous and heterologous neutralization by panels of human HIV+ polyclonal plasma. In independent linked experiments in three laboratories using diverse methodologies and common reagents, no defined pattern of genetic subtype-specific neutralization was observed. Most plasma tested were broadly cross-neutralizing across two or more genetic subtypes, although the titer of neutralization varied across a wide range. We conclude that the genetic subtypes of HIV-1 are not classical neutralization serotypes.
引用
收藏
页码:7827 / 7832
页数:6
相关论文
共 50 条
  • [1] Neutralization kinetics of sensitive and resistant subtype B primary human immunodeficiency virus type 1 isolates
    Davis, D
    Donners, H
    Willems, B
    Ntemgwa, M
    Vermoesen, T
    van der Groen, G
    Janssens, W
    JOURNAL OF MEDICAL VIROLOGY, 2006, 78 (07) : 864 - 876
  • [2] Genetic and functional diversity of human immunodeficiency virus type 1 subtype B Nef primary isolates
    Foster, JL
    Molina, RP
    Luo, T
    Arora, VK
    Huang, YX
    Ho, DD
    Garcia, JV
    JOURNAL OF VIROLOGY, 2001, 75 (04) : 1672 - 1680
  • [3] Neutralization of primary human immunodeficiency virus type 1 isolates: A study of parameters implicated in neutralization in vitro
    Moog, C
    Spenlehauer, C
    Fleury, H
    Heshmati, F
    Saragosti, S
    Letourneur, F
    Kirn, A
    Aubertin, AM
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (01) : 19 - 27
  • [4] Antibody neutralization-resistant primary isolates of human immunodeficiency virus type 1
    Parren, PWHI
    Wang, M
    Trkola, A
    Binley, JM
    Purtscher, M
    Katinger, H
    Moore, JP
    Burton, DR
    JOURNAL OF VIROLOGY, 1998, 72 (12) : 10270 - 10274
  • [5] Inter- and intraclade neutralization of human immunodeficiency virus type 1: Genetic clades do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes
    Moore, JP
    Cao, YZ
    Leu, J
    Qin, LM
    Korber, B
    Ho, DD
    JOURNAL OF VIROLOGY, 1996, 70 (01) : 427 - 444
  • [6] Inter- and intra-subtype neutralization of human immunodeficiency virus type-1
    Bradac, J
    RETROVIRUSES OF HUMAN AIDS AND RELATED ANIMAL DISEASES, 1996, : 87 - 95
  • [7] CROSS-NEUTRALIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2 AND SIMIAN IMMUNODEFICIENCY VIRUS ISOLATES
    ROBERTGUROFF, M
    ALDRICH, K
    MULDOON, R
    STERN, TL
    BANSAL, GP
    MATTHEWS, TJ
    MARKHAM, PD
    GALLO, RC
    FRANCHINI, G
    JOURNAL OF VIROLOGY, 1992, 66 (06) : 3602 - 3608
  • [8] Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage
    Cecilia, D
    Kewalramani, VN
    O'Leary, J
    Volsky, B
    Nyambi, P
    Burda, S
    Xu, S
    Littman, DR
    Zolla-Pazner, S
    JOURNAL OF VIROLOGY, 1998, 72 (09) : 6988 - 6996
  • [9] Human immunodeficiency virus type 1 serotypes in Madrid, Spain
    Soriano, V
    Dietrich, U
    Mas, A
    Andersen, R
    Bravo, R
    Ruppach, H
    Gutierrez, M
    MartinezZapico, R
    RubsamenWaigmann, H
    GonzalezLahoz, J
    MEDICINA CLINICA, 1997, 108 (06): : 217 - 220
  • [10] Neutralization synergy of human immunodeficiency virus type 1 primary isolates by cocktails of broadly neutralizing antibodies
    Zwick, MB
    Wang, M
    Poignard, P
    Stiegler, G
    Katinger, H
    Burton, DR
    Parren, PWHI
    JOURNAL OF VIROLOGY, 2001, 75 (24) : 12198 - 12208